Genmab Announces Financial Results for the First Nine Months of 2012 and Improves 2012 Financial Guidance

[at noodls] – November 7, 2012; Copenhagen, Denmark; Interim Report for the 9 Months Ended September 30, 2012 Company Announcement Entered global license and development agreement for daratumumab with Janssen Biotech, … more

View todays social media effects on GENC

View the latest stocks trending across Twitter. Click to view dashboard